{"transactions":[{"id":1482617,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-12T20:05:08.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":false,"shares":155400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.295,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":155400},"source":{"system":"sec-edgar","filing":"0000950170-24-072420","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024072420/ownership.xml","form_type":"4"}},{"id":1482616,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-12T20:05:08.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.06,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-072420","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024072420/ownership.xml","form_type":"4"}},{"id":1482615,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-12T20:05:08.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":false,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in a series of 48 consecutive equal monthly installments commencing February 16, 2022 (of which 112,500 shares were vested as of the exercise date), provided the optionee continues to provide services to the Company."}],"balance_after":87500,"derivative":{"exercise_price":1.06,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0000950170-24-072420","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024072420/ownership.xml","form_type":"4"}},{"id":1482614,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-12T20:05:08.000Z","date":"2024-06-10","kind":"sale","planned":false,"acquired":false,"shares":287900,"price":4.634,"value":1334128.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-072420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024072420/ownership.xml","form_type":"4"}},{"id":1482613,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-12T20:05:08.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":true,"shares":155400,"price":1.295,"value":201243.0,"ownership":{"direct":true},"balance_after":155400,"source":{"system":"sec-edgar","filing":"0000950170-24-072420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024072420/ownership.xml","form_type":"4"}},{"id":1482612,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-12T20:05:08.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":1.06,"value":21200.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-24-072420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024072420/ownership.xml","form_type":"4"}},{"id":1482611,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-12T20:05:08.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":true,"shares":112500,"price":1.06,"value":119250.0,"ownership":{"direct":true},"balance_after":112500,"source":{"system":"sec-edgar","filing":"0000950170-24-072420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024072420/ownership.xml","form_type":"4"}},{"id":1487613,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-07T20:10:06.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance-based stock option granted on July 9, 2022 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS."}],"balance_after":200000,"derivative":{"exercise_price":1.93,"expiration_date":"2032-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-24-070622","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024070622/ownership.xml","form_type":"4"}},{"id":1487612,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-07T20:10:06.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Performance-based stock option granted on February 16, 2022 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS."}],"balance_after":50000,"derivative":{"exercise_price":1.06,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-070622","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024070622/ownership.xml","form_type":"4"}},{"id":1639462,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-16T21:11:53.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of 48 consecutive equal monthly installments commencing February 14, 2024, provided the optionee continues to provide service to the Company."}],"balance_after":750000,"derivative":{"exercise_price":2.1,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001415889-24-004109","document":"form4-02162024_090243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000141588924004109/form4-02162024_090243.xml","form_type":"4"}},{"id":1775833,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-09-22T00:31:49.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Performance-based stock option granted on July 8, 2022 and vested in full on August 15, 2023 upon acceptance of the NDA by the\nUS FDA for imetelstat in lower risk MDS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance-based stock option granted on July 8, 2022 and vested in full on August 15, 2023 upon acceptance of the NDA by the\nUS FDA for imetelstat in lower risk MDS."}],"balance_after":180000,"derivative":{"exercise_price":1.93,"exercise_date":"2023-08-15","expiration_date":"2032-07-07","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001062993-23-018391","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323018391/form4.xml","form_type":"4"}},{"id":1775832,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-09-22T00:31:49.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Performance-based stock option granted on February 16, 2022 and vested in full on August 15, 2023 upon acceptance of the NDA by the\nUS FDA for imetelstat in lower risk MDS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Performance-based stock option granted on February 16, 2022 and vested in full on August 15, 2023 upon acceptance of the NDA by the\nUS FDA for imetelstat in lower risk MDS."}],"balance_after":20000,"derivative":{"exercise_price":1.06,"exercise_date":"2023-08-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001062993-23-018391","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323018391/form4.xml","form_type":"4"}},{"id":1994378,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-25T00:17:38.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":540000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of 48 consecutive equal monthly installments commencing February 22, 2023, provided the optionee continues to provide services to the Company."}],"balance_after":540000,"derivative":{"exercise_price":2.83,"expiration_date":"2033-02-21","underlying":"Common Stock","underlying_shares":540000},"source":{"system":"sec-edgar","filing":"0001062993-23-004900","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323004900/form4.xml","form_type":"4"}},{"id":2208795,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":90018,"kind":"person","name":"Feller Faye","position":1,"cik":"0001937361","reported_name":"Feller Faye","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-12T15:52:01.000Z","date":"2022-07-08","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of 48 consecutive equal monthly installments commencing July 9, 2022, provided the optionee continues to provide services to the Company."}],"balance_after":120000,"derivative":{"exercise_price":1.93,"expiration_date":"2032-07-07","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001062993-22-016245","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299322016245/form4.xml","form_type":"4"}}]}